Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date of rights not otherwise specified in the taxonomy having a projected indefinite period of benefit.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Name:	us-gaap_OtherIndefiniteLivedIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Collaborative Arrangement, Change of Control Prior to Clinical Trial, Time Period of Notice Required to Terminate

No definition available.

Name:	vrtx_CollaborativeArrangementChangeofControlPriortoClinicalTrialTimePeriodofNoticeRequiredtoTerminate
Namespace Prefix:	vrtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the potential milestone amount to be paid by the entity under the collaboration agreement if drug candidates are approved and commercialized.

No definition available.

Name:	vrtx_CollaborativeArrangementDevelopmentAndRegulatoryPotentialMilestonePaymentsMaximum
Namespace Prefix:	vrtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Collaborative Arrangement, Prior to Marketing Approval, Time Period of Notice Required to Terminate

No definition available.

Name:	vrtx_CollaborativeArrangementPriortoMarketingApprovalTimePeriodofNoticeRequiredtoTerminate
Namespace Prefix:	vrtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the potential milestone amount to be paid by the entity under the collaboration agreement if drug candidates are commercialized.

No definition available.

Name:	vrtx_CollaborativeArrangementRegulatoryPotentialMilestonePaymentsMaximum
Namespace Prefix:	vrtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Collaborative Arrangement, Subsequent to Marketing Approval, Time Period of Notice Required to Terminate

No definition available.

Name:	vrtx_CollaborativeArrangementSubsequenttoMarketingApprovalTimePeriodofNoticeRequiredtoTerminate
Namespace Prefix:	vrtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Collaborative Arrangement, Term of Agreement Following First Commercial Sale

No definition available.

Name:	vrtx_CollaborativeArrangementTermofAgreementFollowingFirstCommercialSale
Namespace Prefix:	vrtx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The amount of the up-front license fee paid by the entity pursuant to a collaborative arrangement.

No definition available.

Name:	vrtx_CollaborativeArrangementUpFrontLicenseFee
Namespace Prefix:	vrtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	vrtx_CollaborativeArrangementsByAgreementAxis=vrtx_ParionSciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	vrtx_DrugCandidateAxis=vrtx_EnacInhibitorsinCfMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	vrtx_DrugCandidateAxis=vrtx_EnacInhibitorsinNonCfMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: